News

Diabetes Treatment Costs Vastly Exceed Reimbursement


 

FROM A TELECONFERENCE CONDUCTED BY AVALERE HEALTH

• Create strong provider teams and share roles and expectations with patients.

For payment reform, they recommended:

• Reimburse providers appropriately for meeting standards of care in treating their patients by paying adequately for all services delivered.

• Test and implement payment models that reward providers for supplying optimal care to patients with diabetes.

And to address workforce supply:

• Work to make diabetes care an attractive choice for new medical professionals through educational loan forgiveness.

• Promote the importance of providing optimal diabetes care as an essential aspect of the health care system.

• Expand access to diabetes modules to educate primary care providers on treatment of diabetes.

The study was funded by Medtronic, Abbott, Bayer, DexCom, Johnson & Johnson, Roche, and Sanofi-Aventis. However, the working group members were not individually compensated.

Pages

Recommended Reading

Investigational Chemokine Receptor Reduces Hemoglobin A1c
MDedge Internal Medicine
Gastric Bypass's Metabolic Gains Persist at 6 Years
MDedge Internal Medicine
Educational Interventions Modestly Improve Glucose Control
MDedge Internal Medicine
'Coaching' Fails to Improve Diabetes in Disadvantaged Patients
MDedge Internal Medicine
Motivational Interviewing Lowers Cardiometabolic Risk
MDedge Internal Medicine
Stroke Risk Surges After 10 Years in Diabetes Patients
MDedge Internal Medicine
B Vitamins Fail to Cut Fracture Risk in Women
MDedge Internal Medicine
Cardiac Risk in Diabetes Often Overestimated
MDedge Internal Medicine
Bariatric Surgery Recipients' Family Members Slim Down
MDedge Internal Medicine
Obesity Drug Resubmitted for FDA Approval
MDedge Internal Medicine